Ruth Wood, co-creator of the Honeycomb maze, describes how the new test overcomes the challenges of its predecessors, and how it can be utilized across the spectrum of neuroscience research.
Russell Kern reports on the 6-month update on the first-in-human clinical study of neural stem cells in patients with Parkinson’s disease.
In these interviews, we speak to four early career researchers whose respective research findings were highlighted by the Society as ones to watch in the coming years.
Jeff describes how dysfunction in the glymphatic system could contribute to Alzheimer’s disease, and how our growing knowledge in this area could be harnessed to develop new disease-modifying treatments.
Prof Kipnis describes his lab’s discovery that meningeal vessels directly link the brain with the lymphatic system, overturning decades of teaching that the brain lacks a direct connection to the immune system.
Lauren Pulling sat down with Nicole Swann at Neuroscience 2017 to hear more about her work on a novel implantable device capable of delivering adaptive DBS.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Doris Doudet to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson’s disease rat model.
In this #NCTalks podcast, we speak to Henrik Zetterberg; one of the world’s leading experts in fluid biomarkers for neuronal injury and degeneration.